25 XP   0   0   10

Rapid Therapeutic Science Lab inc
Buy, Hold or Sell?

Let's analyse Rapid Therapeutic Science Lab inc together

PenkeI guess you are interested in Rapid Therapeutic Science Lab inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Rapid Therapeutic Science Lab inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Rapid Therapeutic Science Lab inc

I send you an email if I find something interesting about Rapid Therapeutic Science Lab inc.

Quick analysis of Rapid Therapeutic Science Lab inc (30 sec.)










What can you expect buying and holding a share of Rapid Therapeutic Science Lab inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$-0.31
Expected worth in 1 year
$-0.29
How sure are you?
29.4%

+ What do you gain per year?

Total Gains per Share
$0.02
Return On Investment
407.6%

For what price can you sell your share?

Current Price per Share
$0.01
Expected price per share
$0.005 - $0.005
How sure are you?
50%

1. Valuation of Rapid Therapeutic Science Lab inc (5 min.)




Live pricePrice per Share (EOD)

$0.01

Intrinsic Value Per Share

$-1.57 - $-1.79

Total Value Per Share

$-1.88 - $-2.11

2. Growth of Rapid Therapeutic Science Lab inc (5 min.)




Is Rapid Therapeutic Science Lab inc growing?

Current yearPrevious yearGrowGrow %
How rich?-$2.7m-$1.8m-$1m-37.2%

How much money is Rapid Therapeutic Science Lab inc making?

Current yearPrevious yearGrowGrow %
Making money$23.9k-$1.2m$1.2m5,208.0%
Net Profit Margin0.0%-797,890.6%--

How much money comes from the company's main activities?

3. Financial Health of Rapid Therapeutic Science Lab inc (5 min.)




4. Comparing to competitors in the Medical Devices industry (5 min.)




  Industry Rankings (Medical Devices)  


Richest
#314 / 332

Most Revenue
#319 / 332

Most Profit
#160 / 332

Most Efficient
#117 / 332

What can you expect buying and holding a share of Rapid Therapeutic Science Lab inc? (5 min.)

Welcome investor! Rapid Therapeutic Science Lab inc's management wants to use your money to grow the business. In return you get a share of Rapid Therapeutic Science Lab inc.

What can you expect buying and holding a share of Rapid Therapeutic Science Lab inc?

First you should know what it really means to hold a share of Rapid Therapeutic Science Lab inc. And how you can make/lose money.

Speculation

The Price per Share of Rapid Therapeutic Science Lab inc is $0.005. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Rapid Therapeutic Science Lab inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Rapid Therapeutic Science Lab inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $-0.31. Based on the TTM, the Book Value Change Per Share is $0.01 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.09 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Rapid Therapeutic Science Lab inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps0.01105.1%0.00-49.7%-0.10-1,933.2%-0.05-1,047.6%-0.03-589.3%
Usd Book Value Change Per Share0.01222.9%0.01101.9%-0.09-1,877.0%-0.02-327.7%-0.01-187.5%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.01222.9%0.01101.9%-0.09-1,877.0%-0.02-327.7%-0.01-187.5%
Usd Price Per Share0.06-0.54-5.40-9.24-6.84-
Price to Earnings Ratio3.04-8.61--42.81--207.88--879.29-
Price-to-Total Gains Ratio5.74--43.62-160.90--69.84--1,744.81-
Price to Book Ratio-0.21--1.56--102.55--147.93--134.61-
Price-to-Total Gains Ratio5.74--43.62-160.90--69.84--1,744.81-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.005
Number of shares200000
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.01-0.02
Usd Total Gains Per Share0.01-0.02
Gains per Quarter (200000 shares)1,019.00-3,277.34
Gains per Year (200000 shares)4,076.02-13,109.36
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10407640660-13109-13119
20815281420-26219-26228
3012228122180-39328-39337
4016304162940-52437-52446
5020380203700-65547-65555
6024456244460-78656-78664
7028532285220-91766-91773
8032608325980-104875-104882
9036684366740-117984-117991
10040760407500-131094-131100

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share3.01.00.075.0%3.08.00.027.3%3.016.00.015.8%3.031.00.08.8%3.032.00.08.6%
Book Value Change Per Share2.02.00.050.0%5.06.00.045.5%7.011.01.036.8%10.023.01.029.4%11.023.01.031.4%
Dividend per Share0.00.04.00.0%0.00.011.00.0%0.00.019.00.0%0.00.034.00.0%0.00.035.00.0%
Total Gains per Share2.02.00.050.0%5.06.00.045.5%7.011.01.036.8%10.023.01.029.4%11.023.01.031.4%

Fundamentals of Rapid Therapeutic Science Lab inc

About Rapid Therapeutic Science Lab inc

Rapid Therapeutic Science Laboratories, Inc. operates as a biotech company, provides natural based relief through aerosol delivery systems for non-psychoactive cannabinoids. The company was formerly known as Holly Brothers Pictures, Inc. and changed its name to Rapid Therapeutic Science Laboratories, Inc. in January 2020. Rapid Therapeutic Science Laboratories, Inc. was incorporated in 2013 and is based in Dallas, Texas.

Fundamental data was last updated by Penke on 2024-04-24 22:37:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is underpriced.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Rapid Therapeutic Science Lab inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Rapid Therapeutic Science Lab inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Rapid Therapeutic Science Lab inc to the Medical Devices industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Rapid Therapeutic Science Lab inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-797,890.6%+797,890.6%
TTM-5Y-176,900.8%+176,900.8%
5Y-176,900.8%10Y-98,856.3%-78,044.5%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ--14.8%+14.8%
TTM--19.6%+19.6%
YOY-797,890.6%-13.4%-797,877.2%
5Y-176,900.8%-20.4%-176,880.4%
10Y-98,856.3%-27.3%-98,829.0%
1.1.2. Return on Assets

Shows how efficient Rapid Therapeutic Science Lab inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Rapid Therapeutic Science Lab inc to the Medical Devices industry mean.
  • 2.2% Return on Assets means that Rapid Therapeutic Science Lab inc generated $0.02 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Rapid Therapeutic Science Lab inc:

  • The MRQ is 2.2%. Using its assets, the company is less efficient in making profit.
  • The TTM is 1.9%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ2.2%TTM1.9%+0.3%
TTM1.9%YOY-50.5%+52.5%
TTM1.9%5Y-1,315.6%+1,317.5%
5Y-1,315.6%10Y-768.1%-547.5%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ2.2%-4.0%+6.2%
TTM1.9%-4.3%+6.2%
YOY-50.5%-4.3%-46.2%
5Y-1,315.6%-3.8%-1,311.8%
10Y-768.1%-4.8%-763.3%
1.1.3. Return on Equity

Shows how efficient Rapid Therapeutic Science Lab inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Rapid Therapeutic Science Lab inc to the Medical Devices industry mean.
  • 0.0% Return on Equity means Rapid Therapeutic Science Lab inc generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Rapid Therapeutic Science Lab inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-10.3%+10.3%
5Y-10.3%10Y-16.6%+6.3%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ--4.2%+4.2%
TTM--5.6%+5.6%
YOY--5.3%+5.3%
5Y-10.3%-6.0%-4.3%
10Y-16.6%-6.7%-9.9%

1.2. Operating Efficiency of Rapid Therapeutic Science Lab inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Rapid Therapeutic Science Lab inc is operating .

  • Measures how much profit Rapid Therapeutic Science Lab inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Rapid Therapeutic Science Lab inc to the Medical Devices industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Rapid Therapeutic Science Lab inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-507,080.9%+507,080.9%
TTM-5Y-115,544.6%+115,544.6%
5Y-115,544.6%10Y-64,569.1%-50,975.6%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ--24.9%+24.9%
TTM--15.9%+15.9%
YOY-507,080.9%-13.4%-507,067.5%
5Y-115,544.6%-19.6%-115,525.0%
10Y-64,569.1%-25.7%-64,543.4%
1.2.2. Operating Ratio

Measures how efficient Rapid Therapeutic Science Lab inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Devices industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Rapid Therapeutic Science Lab inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY5,071.309-5,071.309
TTM-5Y1,196.927-1,196.927
5Y1,196.92710Y668.871+528.056
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-1.430-1.430
TTM-1.424-1.424
YOY5,071.3091.389+5,069.920
5Y1,196.9271.416+1,195.511
10Y668.8711.375+667.496

1.3. Liquidity of Rapid Therapeutic Science Lab inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Rapid Therapeutic Science Lab inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Devices industry mean).
  • A Current Ratio of 0.07 means the company has $0.07 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Rapid Therapeutic Science Lab inc:

  • The MRQ is 0.072. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.056. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.072TTM0.056+0.016
TTM0.056YOY0.208-0.152
TTM0.0565Y0.278-0.222
5Y0.27810Y0.712-0.435
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0722.688-2.616
TTM0.0562.720-2.664
YOY0.2083.431-3.223
5Y0.2783.629-3.351
10Y0.7123.526-2.814
1.3.2. Quick Ratio

Measures if Rapid Therapeutic Science Lab inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Rapid Therapeutic Science Lab inc to the Medical Devices industry mean.
  • A Quick Ratio of 0.02 means the company can pay off $0.02 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Rapid Therapeutic Science Lab inc:

  • The MRQ is 0.019. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.006. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.019TTM0.006+0.013
TTM0.006YOY0.136-0.130
TTM0.0065Y0.144-0.138
5Y0.14410Y0.580-0.436
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0191.527-1.508
TTM0.0061.676-1.670
YOY0.1362.142-2.006
5Y0.1442.328-2.184
10Y0.5802.439-1.859

1.4. Solvency of Rapid Therapeutic Science Lab inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Rapid Therapeutic Science Lab inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Rapid Therapeutic Science Lab inc to Medical Devices industry mean.
  • A Debt to Asset Ratio of 2.32 means that Rapid Therapeutic Science Lab inc assets are financed with 232.0% credit (debt) and the remaining percentage (100% - 232.0%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Rapid Therapeutic Science Lab inc:

  • The MRQ is 2.320. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 2.365. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ2.320TTM2.365-0.044
TTM2.365YOY1.751+0.614
TTM2.3655Y344.095-341.731
5Y344.09510Y193.509+150.586
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ2.3200.399+1.921
TTM2.3650.390+1.975
YOY1.7510.348+1.403
5Y344.0950.442+343.653
10Y193.5090.458+193.051
1.4.2. Debt to Equity Ratio

Measures if Rapid Therapeutic Science Lab inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Rapid Therapeutic Science Lab inc to the Medical Devices industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Rapid Therapeutic Science Lab inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y0.099-0.099
5Y0.09910Y-0.100+0.199
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.576-0.576
TTM-0.564-0.564
YOY-0.497-0.497
5Y0.0990.626-0.527
10Y-0.1000.696-0.796

2. Market Valuation of Rapid Therapeutic Science Lab inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Rapid Therapeutic Science Lab inc generates.

  • Above 15 is considered overpriced but always compare Rapid Therapeutic Science Lab inc to the Medical Devices industry mean.
  • A PE ratio of 3.04 means the investor is paying $3.04 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Rapid Therapeutic Science Lab inc:

  • The EOD is 0.238. Based on the earnings, the company is cheap. +2
  • The MRQ is 3.044. Based on the earnings, the company is cheap. +2
  • The TTM is 8.605. Based on the earnings, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD0.238MRQ3.044-2.806
MRQ3.044TTM8.605-5.561
TTM8.605YOY-42.812+51.418
TTM8.6055Y-207.882+216.488
5Y-207.88210Y-879.286+671.404
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD0.238-1.068+1.306
MRQ3.044-1.808+4.852
TTM8.605-2.273+10.878
YOY-42.812-2.832-39.980
5Y-207.882-2.706-205.176
10Y-879.286-2.092-877.194
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Rapid Therapeutic Science Lab inc:

  • The EOD is -1.507. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -19.292. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -10.225. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.507MRQ-19.292+17.785
MRQ-19.292TTM-10.225-9.067
TTM-10.225YOY-18.921+8.696
TTM-10.2255Y-650.239+640.014
5Y-650.23910Y-967.592+317.353
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-1.507-1.087-0.420
MRQ-19.292-1.956-17.336
TTM-10.225-3.221-7.004
YOY-18.921-6.238-12.683
5Y-650.239-5.353-644.886
10Y-967.592-5.623-961.969
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Rapid Therapeutic Science Lab inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Devices industry mean).
  • A PB ratio of -0.21 means the investor is paying $-0.21 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Rapid Therapeutic Science Lab inc:

  • The EOD is -0.016. Based on the equity, the company is expensive. -2
  • The MRQ is -0.206. Based on the equity, the company is expensive. -2
  • The TTM is -1.558. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.016MRQ-0.206+0.190
MRQ-0.206TTM-1.558+1.351
TTM-1.558YOY-102.545+100.987
TTM-1.5585Y-147.928+146.370
5Y-147.92810Y-134.611-13.317
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-0.0162.011-2.027
MRQ-0.2062.384-2.590
TTM-1.5582.593-4.151
YOY-102.5453.198-105.743
5Y-147.9284.005-151.933
10Y-134.6114.393-139.004
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Rapid Therapeutic Science Lab inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.0110.005+119%-0.094+942%-0.016+247%-0.009+184%
Book Value Per Share---0.310-0.334+8%-0.210-32%-0.218-30%-0.121-61%
Current Ratio--0.0720.056+29%0.208-65%0.278-74%0.712-90%
Debt To Asset Ratio--2.3202.365-2%1.751+33%344.095-99%193.509-99%
Debt To Equity Ratio----0%-0%0.099-100%-0.1000%
Dividend Per Share----0%-0%-0%-0%
Eps--0.005-0.002+147%-0.097+1939%-0.052+1097%-0.029+661%
Free Cash Flow Per Share---0.001-0.023+2686%-0.071+8448%-0.033+3893%-0.019+2153%
Free Cash Flow To Equity Per Share---0.002-0.019+995%0.010-118%-0.002-9%-0.001-48%
Gross Profit Margin--1.0001.0000%1.0000%1.006-1%1.0030%
Intrinsic Value_10Y_max---1.795--------
Intrinsic Value_10Y_min---1.566--------
Intrinsic Value_1Y_max---0.205--------
Intrinsic Value_1Y_min---0.201--------
Intrinsic Value_3Y_max---0.597--------
Intrinsic Value_3Y_min---0.570--------
Intrinsic Value_5Y_max---0.966--------
Intrinsic Value_5Y_min---0.898--------
Market Cap44161.250-1180%565264.0004789287.563-88%47683109.688-99%221235834.059-100%138493998.537-100%
Net Profit Margin----0%-7978.9060%-1769.0080%-988.5630%
Operating Margin----0%-5070.8090%-1155.4460%-645.6910%
Operating Ratio----0%5071.309-100%1196.927-100%668.871-100%
Pb Ratio-0.016+92%-0.206-1.558+655%-102.545+49591%-147.928+71582%-134.611+65129%
Pe Ratio0.238-1180%3.0448.605-65%-42.812+1506%-207.882+6929%-879.286+28984%
Price Per Share0.005-1180%0.0640.542-88%5.399-99%9.238-99%6.845-99%
Price To Free Cash Flow Ratio-1.507+92%-19.292-10.225-47%-18.921-2%-650.239+3270%-967.592+4915%
Price To Total Gains Ratio0.449-1180%5.743-43.619+859%160.896-96%-69.841+1316%-1744.812+30480%
Quick Ratio--0.0190.006+232%0.136-86%0.144-87%0.580-97%
Return On Assets--0.0220.019+17%-0.505+2359%-13.156+58887%-7.681+34421%
Return On Equity----0%-0%-0.1030%-0.1660%
Total Gains Per Share--0.0110.005+119%-0.094+942%-0.016+247%-0.009+184%
Usd Book Value---2739134.000-2951293.750+8%-1852337.750-32%-1992072.684-27%-1109506.971-59%
Usd Book Value Change Per Share--0.0110.005+119%-0.094+942%-0.016+247%-0.009+184%
Usd Book Value Per Share---0.310-0.334+8%-0.210-32%-0.218-30%-0.121-61%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps--0.005-0.002+147%-0.097+1939%-0.052+1097%-0.029+661%
Usd Free Cash Flow---7325.000-204046.750+2686%-626120.250+8448%-300147.789+3998%-169283.000+2211%
Usd Free Cash Flow Per Share---0.001-0.023+2686%-0.071+8448%-0.033+3893%-0.019+2153%
Usd Free Cash Flow To Equity Per Share---0.002-0.019+995%0.010-118%-0.002-9%-0.001-48%
Usd Market Cap44161.250-1180%565264.0004789287.563-88%47683109.688-99%221235834.059-100%138493998.537-100%
Usd Price Per Share0.005-1180%0.0640.542-88%5.399-99%9.238-99%6.845-99%
Usd Profit--46422.00023951.250+94%-1223435.250+2735%-549039.526+1283%-308530.088+765%
Usd Revenue----0%27.500-100%7399.421-100%4134.971-100%
Usd Total Gains Per Share--0.0110.005+119%-0.094+942%-0.016+247%-0.009+184%
 EOD+2 -6MRQTTM+23 -4YOY+14 -155Y+16 -1510Y+15 -15

3.2. Fundamental Score

Let's check the fundamental score of Rapid Therapeutic Science Lab inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-150.238
Price to Book Ratio (EOD)Between0-1-0.016
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.019
Current Ratio (MRQ)Greater than10.072
Debt to Asset Ratio (MRQ)Less than12.320
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.050.022
Total2/10 (20.0%)

3.3. Technical Score

Let's check the technical score of Rapid Therapeutic Science Lab inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose0.005
Total0/1 (0.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-06-302022-09-302022-12-312023-03-312023-06-30
EBITDA  -101-245-346315-30-62-9212027



Latest Balance Sheet

Balance Sheet of 2023-06-30. Currency in USD. All numbers in thousands.

Summary
Total Assets2,074
Total Liabilities4,813
Total Stockholder Equity-2,739
 As reported
Total Liabilities 4,813
Total Stockholder Equity+ -2,739
Total Assets = 2,074

Assets

Total Assets2,074
Total Current Assets318
Long-term Assets1,756
Total Current Assets
Cash And Cash Equivalents 2
Net Receivables 83
Inventory 175
Other Current Assets 58
Total Current Assets  (as reported)318
Total Current Assets  (calculated)318
+/-0
Long-term Assets
Property Plant Equipment 1,586
Intangible Assets 170
Long-term Assets  (as reported)1,756
Long-term Assets  (calculated)1,756
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities4,426
Long-term Liabilities388
Total Stockholder Equity-2,739
Total Current Liabilities
Short-term Debt 3,398
Short Long Term Debt 3,297
Accounts payable 770
Other Current Liabilities 84
Total Current Liabilities  (as reported)4,426
Total Current Liabilities  (calculated)7,549
+/- 3,123
Long-term Liabilities
Capital Lease Obligations 339
Long-term Liabilities  (as reported)388
Long-term Liabilities  (calculated)339
+/- 49
Total Stockholder Equity
Common Stock9
Retained Earnings -10,078
Other Stockholders Equity 7,330
Total Stockholder Equity (as reported)-2,739
Total Stockholder Equity (calculated)-2,739
+/-0
Other
Capital Stock9
Cash and Short Term Investments 2
Common Stock Shares Outstanding 8,318
Current Deferred Revenue174
Liabilities and Stockholders Equity 2,074
Net Debt 3,784
Net Invested Capital 708
Net Tangible Assets -2,909
Net Working Capital -4,108
Property Plant and Equipment Gross 1,652
Short Long Term Debt Total 3,786



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302017-12-312017-09-302017-06-302016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-30
> Total Assets 
38
34
29
23
23
19
12
11
11
6
2
10
3
11
7
7
1
5
26
5
1
1
3
453
445
519
802
1,156
1,013
2,029
2,200
2,692
2,430
2,286
2,255
2,034
2,074
2,0742,0342,2552,2862,4302,6922,2002,0291,0131,15680251944545331152651771131026111112192323293438
   > Total Current Assets 
38
34
29
23
23
19
12
11
11
6
2
10
3
11
7
7
1
5
22
1
1
1
3
125
142
242
459
372
215
1,158
419
279
354
238
233
251
318
3182512332383542794191,15821537245924214212531112251771131026111112192323293438
       Cash And Cash Equivalents 
22
21
20
19
19
19
11
10
10
5
2
9
2
10
6
7
1
5
12
1
1
1
3
125
136
213
266
185
48
920
192
33
112
-397
-379
18
2
218-379-39711233192920481852662131361253111125176102925101011191919202122
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
397
379
0
83
830379397000000000000000000000000000000000
       Other Current Assets 
16
12
8
4
4
1
1
1
1
1
1
1
1
1
1
0
0
0
10
0
0
0
0
0
0
0
0
0
0
52
52
71
67
63
58
58
58
585858636771525200000000001000011111111114481216
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4
4
0
0
0
328
303
278
343
784
798
870
1,781
2,412
2,076
2,049
2,021
1,784
1,756
1,7561,7842,0212,0492,0762,4121,78187079878434327830332800044000000000000000000
       Property Plant Equipment 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
91
614
628
700
1,611
2,242
1,906
1,879
1,851
1,614
1,586
1,5861,6141,8511,8791,9062,2421,6117006286149100000000000000000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4
4
0
0
0
328
303
278
253
170
170
170
170
170
170
170
170
170
170
17017017017017017017017017017025327830332800044000000000000000000
       Other Assets 
0
0
0
0
7
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000000000070000
> Total Liabilities 
-38
-34
-29
0
4
6
-12
0
1
-6
-2
11
11
23
21
30
35
-5
2,889
2,992
3,170
3,170
3,287
1,681
1,809
1,871
1,296
278
617
2,195
3,582
5,633
5,349
5,373
5,396
4,872
4,813
4,8134,8725,3965,3735,3495,6333,5822,1956172781,2961,8711,8091,6813,2873,1703,1702,9922,889-5353021231111-2-610-12640-29-34-38
   > Total Current Liabilities 
0
0
0
0
4
6
0
0
1
0
0
11
11
23
21
30
35
0
689
792
970
970
1,087
1,216
1,494
1,555
981
128
467
2,045
3,053
5,124
4,861
4,905
4,966
4,463
4,426
4,4264,4634,9664,9054,8615,1243,0532,0454671289811,5551,4941,2161,087970970792689035302123111100100640000
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
645
717
741
741
757
757
907
914
390
48
298
738
1,457
2,701
3,013
3,316
3,400
3,367
3,398
3,3983,3673,4003,3163,0132,7011,45773829848390914907757757741741717645000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
741
749
757
757
907
914
390
48
298
738
1,383
2,625
2,936
3,236
3,302
3,267
3,297
3,2973,2673,3023,2362,9362,6251,3837382984839091490775775774974100000000000000000000
       Accounts payable 
0
0
0
0
4
6
0
0
1
0
0
1
1
3
1
0
0
0
15
2
20
20
28
122
65
83
69
45
130
119
465
1,200
705
858
891
735
770
7707358918587051,20046511913045698365122282020215000131100100640000
       Other Current Liabilities 
0
0
0
0
0
0
0
0
0
0
0
10
10
20
20
30
35
0
29
72
0
209
302
337
491
45
84
35
38
1,147
1,085
1,224
1,143
731
674
361
84
843616747311,1431,2241,0851,1473835844549133730220907229035302020101000000000000
   > Long-term Liabilities 
0
0
0
0
4
6
0
0
1
0
0
1
1
3
1
0
0
0
2,200
2,200
2,200
2,200
2,200
465
315
315
315
150
150
150
529
509
489
468
430
409
388
3884094304684895095291501501503153153154652,2002,2002,2002,2002,200000131100100640000
> Total Stockholder Equity
38
34
29
23
23
14
12
11
11
6
2
-1
-8
-11
-14
-23
-34
5
-2,863
-2,987
-3,168
-3,168
-3,284
-1,228
-1,364
-1,351
-494
877
396
-167
-1,382
-2,942
-2,919
-3,087
-3,141
-2,838
-2,739
-2,739-2,838-3,141-3,087-2,919-2,942-1,382-167396877-494-1,351-1,364-1,228-3,284-3,168-3,168-2,987-2,8635-34-23-14-11-8-126111112142323293438
   Common Stock
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
1
1
1
1
1
157
160
162
176
193
194
194
194
8
8
8
8
8
9
98888819419419419317616216015711111333333333333333333
   Retained Earnings -10,078-10,125-10,316-10,365-10,138-10,101-8,521-7,307-6,723-6,187-4,808-4,168-3,601-3,290-3,114-2,977-2,977-2,763-2,628-92-86-75-66-64-60-53-50-47-41-41-40-38-29-29-23-18-14
   Capital Surplus 0000000000000000000000000000000000000
   Treasury Stock0000000000000000000000000000000000000
   Other Stockholders Equity 
49
49
49
49
49
49
49
49
49
49
49
49
49
49
49
49
49
94
-49
-39
0
-193
-171
1,905
2,077
2,655
4,138
6,871
6,926
6,946
6,946
7,152
7,211
7,270
7,167
7,279
7,330
7,3307,2797,1677,2707,2117,1526,9466,9466,9266,8714,1382,6552,0771,905-171-1930-39-49944949494949494949494949494949494949



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-03-31)

Gross Profit (+$)
totalRevenue0
Cost of Revenue-0
Gross Profit00
 
Operating Income (+$)
Gross Profit0
Operating Expense-1,263
Operating Income-1,263-1,263
 
Operating Expense (+$)
Research Development0
Selling General Administrative1,239
Selling And Marketing Expenses0
Operating Expense1,2631,239
 
Net Interest Income (+$)
Interest Income0
Interest Expense-1,896
Other Finance Cost-0
Net Interest Income-1,896
 
Pretax Income (+$)
Operating Income-1,263
Net Interest Income-1,896
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-1,795-732
EBIT - interestExpense = -3,159
-1,795
202
Interest Expense1,896
Earnings Before Interest and Taxes (EBIT)-1,263101
Earnings Before Interest and Taxes (EBITDA)-1,239
 
After tax Income (+$)
Income Before Tax-1,795
Tax Provision-0
Net Income From Continuing Ops-1,795-1,795
Net Income-1,694
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses1,263
Total Other Income/Expenses Net-5311,896
 

Technical Analysis of Rapid Therapeutic Science Lab inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Rapid Therapeutic Science Lab inc. The general trend of Rapid Therapeutic Science Lab inc is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Rapid Therapeutic Science Lab inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Rapid Therapeutic Science Lab inc.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 0.005 < 0.005 < 0.005.

The bearish price targets are: 0.005 > 0.005 > 0.005.

Tweet this
Rapid Therapeutic Science Lab inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Rapid Therapeutic Science Lab inc. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Rapid Therapeutic Science Lab inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Rapid Therapeutic Science Lab inc.

Rapid Therapeutic Science Lab inc Daily Moving Average Convergence/Divergence (MACD) ChartRapid Therapeutic Science Lab inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Rapid Therapeutic Science Lab inc. The current adx is .

Rapid Therapeutic Science Lab inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Rapid Therapeutic Science Lab inc.

Rapid Therapeutic Science Lab inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Rapid Therapeutic Science Lab inc.

Rapid Therapeutic Science Lab inc Daily Relative Strength Index (RSI) ChartRapid Therapeutic Science Lab inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Rapid Therapeutic Science Lab inc.

Rapid Therapeutic Science Lab inc Daily Stochastic Oscillator ChartRapid Therapeutic Science Lab inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Rapid Therapeutic Science Lab inc.

Rapid Therapeutic Science Lab inc Daily Commodity Channel Index (CCI) ChartRapid Therapeutic Science Lab inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Rapid Therapeutic Science Lab inc.

Rapid Therapeutic Science Lab inc Daily Chande Momentum Oscillator (CMO) ChartRapid Therapeutic Science Lab inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Rapid Therapeutic Science Lab inc.

Rapid Therapeutic Science Lab inc Daily Williams %R ChartRapid Therapeutic Science Lab inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Rapid Therapeutic Science Lab inc.

Rapid Therapeutic Science Lab inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Rapid Therapeutic Science Lab inc.

Rapid Therapeutic Science Lab inc Daily Average True Range (ATR) ChartRapid Therapeutic Science Lab inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Rapid Therapeutic Science Lab inc.

Rapid Therapeutic Science Lab inc Daily On-Balance Volume (OBV) ChartRapid Therapeutic Science Lab inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Rapid Therapeutic Science Lab inc.

Rapid Therapeutic Science Lab inc Daily Money Flow Index (MFI) ChartRapid Therapeutic Science Lab inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Rapid Therapeutic Science Lab inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-13MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-19STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-22CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-26WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-27MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-28MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-02STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-03CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-01-09CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-16CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-23MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-26MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-02MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-06WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-04SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-04-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-09RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-10CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-23MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-04-26STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-30MFI SHORT ENTRY LONG CLOSE20 crossover to downside

6.3. Candlestick Patterns

Rapid Therapeutic Science Lab inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Rapid Therapeutic Science Lab inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose0.005
Total0/1 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Rapid Therapeutic Science Lab inc with someone you think should read this too:
  • Are you bullish or bearish on Rapid Therapeutic Science Lab inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Rapid Therapeutic Science Lab inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Rapid Therapeutic Science Lab inc

I send you an email if I find something interesting about Rapid Therapeutic Science Lab inc.


Comments

How you think about this?

Leave a comment

Stay informed about Rapid Therapeutic Science Lab inc.

Receive notifications about Rapid Therapeutic Science Lab inc in your mailbox!